Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Aromatic L-amino acid decarboxylase phosphorylation and activation by PKGIalpha in vitro.

Authors:
Anne-Marie Duchemin Norton H Neff Maria Hadjiconstantinou

J Neurochem 2010 Jul 29;114(2):542-52. Epub 2010 Apr 29.

Division of Molecular Neuropsychopharmacology, Department of Psychiatry, The Ohio State University College of Medicine, Columbus, Ohio 43210, USA.

Brain aromatic L-amino acid decarboxylase (AAAD) is subject to regulation, and phosphorylation might be involved in the short-term activation of the enzyme. Sites for serine/threonine phosphorylation are present in the deduced amino acid sequence of AAAD, and cAMP-dependent protein kinase phosphorylates and activates neuronal AAAD in vitro. We now report that cGMP-dependent protein kinase (PKG) is able to phosphorylate and activate neuronal AAAD. In an in vitro kinase assay, immunoprecipitated native and recombinant mouse brain AAAD was rapidly phosphorylated by exogenous PKGIalpha. When added to striatal homogenates, PKGIalpha increased AAAD activity in a temporal fashion similar to phosphorylation. Recombinant AAAD was also activated by the kinase demonstrating a direct effect. Native enzyme activation was moderate and characterized by increased V(max) and K(m) for L-DOPA. A PKG peptide inhibitor prevented AAAD phosphorylation and activation providing specificity, and causally linking the two events. Together, the findings provide evidence for PKGIalpha-dependent phosphorylation and activation of neuronal AAAD in vitro, and introduce AAAD as a putative PKGIalpha substrate. Neuronal AAAD is best known for its role in the biosynthesis of catecholamines, indoleamines and trace amines in the nervous system, and the biological importance of PKGIalpha phosphorylation in these processes remains to be determined.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1471-4159.2010.06784.xDOI Listing
July 2010

Publication Analysis

Top Keywords

neuronal aaad
16
aaad vitro
12
phosphorylation activation
12
aaad
11
aromatic l-amino
8
l-amino acid
8
acid decarboxylase
8
protein kinase
8
phosphorylation
7
pkgialpha
5
activation
5
linking events
4
events findings
4
brain aaad
4
aaad rapidly
4
mouse brain
4
recombinant mouse
4
specificity causally
4
providing specificity
4
exogenous pkgialpha
4

Altmetric Statistics


Show full details
1 Total Shares
1 Wikipedia Pages
1 Citations

Similar Publications

Aromatic L-amino acid decarboxylase phosphorylation and activation by PKGIalpha in vitro.

Authors:
Anne-Marie Duchemin Norton H Neff Maria Hadjiconstantinou

J Neurochem 2010 Jul 29;114(2):542-52. Epub 2010 Apr 29.

Division of Molecular Neuropsychopharmacology, Department of Psychiatry, The Ohio State University College of Medicine, Columbus, Ohio 43210, USA.

Brain aromatic L-amino acid decarboxylase (AAAD) is subject to regulation, and phosphorylation might be involved in the short-term activation of the enzyme. Sites for serine/threonine phosphorylation are present in the deduced amino acid sequence of AAAD, and cAMP-dependent protein kinase phosphorylates and activates neuronal AAAD in vitro. We now report that cGMP-dependent protein kinase (PKG) is able to phosphorylate and activate neuronal AAAD. Read More

View Article and Full-Text PDF
July 2010
Similar Publications

Blood-brain barrier and neuronal membrane transport of 6-[18F]fluoro-L-DOPA.

Authors:
R E Yee D W Cheng S C Huang M Namavari N Satyamurthy J R Barrio

Biochem Pharmacol 2001 Nov;62(10):1409-15

Department of Molecular and Medical Pharmacology, UCLA School of Medicine, B2-086A Center of the Health Sciences, Los Angeles, CA 90095-6948, USA.

The transport of 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine ([18F]FDOPA) across the blood-brain barrier (BBB) and neuronal membranes was compared with that of L-3,4-dihydroxyphenylalanine (L-DOPA) in rats. The carotid injection method was used as a direct measurement of [18F]FDOPA, 1-[14C]-L-DOPA, and 3-[14C]-L-DOPA transport across the BBB, while isolated nerve terminals were used to examine neuronal membrane transport of [3H]-L-DOPA. [18F]FDOPA appeared to use the same large neutral amino acid carrier for BBB transport as L-DOPA and L-phenylalanine. Read More

View Article and Full-Text PDF
November 2001
Similar Publications

Noninvasive assessment of aromatic L-amino acid decarboxylase activity in aging rhesus monkey brain in vivo.

Authors:
O T Dejesus C J Endres S E Shelton R J Nickles J E Holden

Synapse 2001 Jan;39(1):58-63

Department of Medical Physics, University of Wisconsin Medical School Madison, Wisconsin 53706, USA.

The effect of aging on aromatic L-amino acid decarboxylase (AAAD) activity in rhesus monkey striatum was assessed in vivo using PET imaging. Two analogs of L-DOPA, 6-fluoro-m-tyrosine (FMT) and 6-fluoro-L-DOPA (FDOPA), were used to image rhesus monkeys of various ages. Results show that when the animals were grouped between young (3-11 years) and aged (25-37 years), FDOPA uptake in the older animals showed a 21% decline (P < 0. Read More

View Article and Full-Text PDF
January 2001
Similar Publications

Localization of trapping of 6-[(18)F]fluoro-L-m-tyrosine, an aromatic L-amino acid decarboxylase tracer for PET.

Authors:
W D Brown O T DeJesus R W Pyzalski L Malischke A D Roberts S E Shelton H Uno W D Houser R J Nickles J E Holden

Synapse 1999 Nov;34(2):111-23

Department of Radiology, University of Wisconsin-Madison, USA.

The purpose of this study was to address four major questions regarding 6-FMT, a noncatecholic PET tracer for AAAD: 1) Where is the specific uptake of 6-FMT? 2) Why does it accumulate where and to the degree that it does? 3) How does its uptake differ from that of fluoroDOPA globally? and 4) Does its regional uptake differ significantly from that of fluoroDOPA? High-resolution PET scans were obtained in three rhesus monkeys using 6-FMT and in two of them using fluoroDOPA. Anatomic distribution was analyzed visually and quantitative uptake of 6-FMT was compared with published regional decarboxylase activity and monoamine neurotransmitter concentrations. In addition to high uptake in the dopamine-rich striatal nuclei, there was specific uptake of 6-FMT in brain regions which have little dopaminergic innervation but which have other amines in significant concentration. Read More

View Article and Full-Text PDF
November 1999
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap